Top Medical News
Jairia Dela Cruz, 2 days ago
Use of phosphodiesterase-5 (PDE5) inhibitors following a first myocardial infarction (MI) may reduce the risk of long-term adverse outcomes, including mortality and heart failure hospitalization, in a dose-dependent fashion, according to a Swedish study.
4 days ago
Listening to music does not facilitate a more comfortable urodynamic testing, having little to no impact on pain, anxiety and stress in both men and women, a study has shown. Moreover, women exhibit statistically higher levels of pain and anxiety compared with men, regardless of the presence of music.
6 days ago
Large post-void residual (PVR) volume following onabotulinumtoxin A injection in patients with overactive bladder syndrome (OAB) appear to be associated with low voiding efficiency and low 3-day daytime frequency episodes, a new study reports.
6 days ago
Prior pregnancies appear to carry an increased risk of developing nephrolithiasis in women of reproductive age, a study suggests.
7 days ago
Persistent wetting during childhood is associated with increased nocturia, bedwetting, daytime wetting, passing hard stools and urgency in adolescence, a new study finds.
7 days ago
The bladder training video appears to be as effective as standard urotherapy in reducing bladder/bowel symptoms in children, according to a recent study.
9 days ago
Asian prostate cancer patients may show a significant reduction in bone mineral density (BMD) 12 months after androgen deprivation therapy (ADT) with no difference between those on continuous combined androgen block (CAB) and those on gonadotropin-releasing hormone (GnRH) agonist monotherapy, a new study shows.
Special Reports
Prof Choosak Pripatnanont, 23 Feb 2017
Experience-sharing interview: Managing a complicated case of lower urinary tract symptoms
Dr Colin Teo, 10 Dec 2016

Tolterodine: Experience-sharing interview with Dr Colin Teo

Professor Anthony Chi-Fai Ng, 30 Sep 2016


Experience-sharing interview with Professor Anthony Chi-Fai Ng

Professor Steven A Kaplan, 08 Aug 2016
Recently, at a Pfizer-sponsored continuing medical education event, Dr Steven Kaplan updated Malaysian healthcare professionals on some of the recent clinical advances in the management of male lower urinary tract symptoms (LUTS).
Professor John Mulhall, 06 Aug 2016
In the practice of sexual medicine, the goal of the treating physician is to help the patient (or the couple) return to satisfactory sexual relations. Healthy sexual activity is important, and many, including the elderly population, report of regular sexual activity.1,2 Erectile dysfunction is an important aspect of sexual health that often goes undetected. Crucial barriers to ED discussion in the clinic are patients’ embarrassment or reluctance to discuss the condition and the lack of knowledge or training on the physicians’ side.3
Roshini Claire Anthony, 25 Apr 2016

Elderly patients on androgen deprivation therapy (ADT) as part of prostate cancer treatment may be at an increased risk of depression, a recent study states.

Roshini Claire Anthony, 24 Mar 2016

Salvage radical prostatectomy (SRP) after radiation produces good long-term survival rates in men with prostate adenocarcinoma, according to a recent study.

Conference Reports
Jackey Suen, 24 Feb 2017

Research on the role of circulating tumour DNA (ctDNA) in metastatic castration-resistant prostate cancer (mCRPC) gains momentum, as a new study finds ctDNA assessment promising in the monitoring and prognosis of mCRPC and in identifying new therapeutic targets for the disease.

Dr. Joseph Delano Fule Robles, 22 Feb 2017

A recent study presented at the ASCO Genitourinary Cancers Symposium 2017 held in Orlando, Florida, US showed that antibiotic use in patients with metastatic renal cell carcinoma (mRCC) may dampen the efficacy of PD-1/PD-L1 inhibitors.

Christina Lau, 21 Feb 2017

Patients with castration-resistant prostate cancer (CRPC) may be able to reduce treatment cost by taking low-dose abiraterone acetate with a low-fat breakfast as a study shows noninferiority of the regimen compared with standard dosing on an empty stomach.

Dr. Joseph Delano Fule Robles, 10 Feb 2017

Findings of two studies presented recently at the European Cancer Congress 2017 (ECCO 2017) demonstrates the effect of the PD-1 inhibitor, pembrolizumab, against a rare form of melanoma and bladder cancer. 

Roshini Claire Anthony, 03 Aug 2016

A combination of chemotherapy and androgen deprivation therapy (ADT) is recommended for men with extensive hormone-sensitive prostate cancer, according to a presentation at the 14th Urological Association of Asia (UAA) Congress 2016 held in Singapore. 

Pearl Toh, 03 Aug 2016
Testosterone replacement therapy (TRT) in hypogonadal men was associated with a lower cardiovascular (CV) risk, according to a presentation at the recent Urological Association of Asia Annual Congress (UAA 2016) held in Singapore, allaying concerns about the safety of TRT amidst controversial findings from previous studies.
Elvira Manzano, 03 Aug 2016
Family physicians or GPs, as referred to in many Asian countries, are well positioned to diagnose and treat uncomplicated benign prostatic hyperplasia (BPH), according to a leading urologist. Careful selection of patients is nonetheless crucial when starting therapy.